Personalised exhaled nitric oxygen fraction (FENO)-driven asthma management in primary care: a FENO subgroup analysis of the ACCURATE trial

Background The aim of this study was to identify patients who benefit most from exhaled nitric oxide fraction (FENO)-driven asthma management in primary care, based on prespecified subgroups with different levels of FENO. Methods We used data from 179 adults with asthma from a 12-month primary care...

Full description

Bibliographic Details
Main Authors: Suzanne Boer, Persijn J. Honkoop, Rik J.B. Loijmans, Jiska B. Snoeck-Stroband, Willem J.J. Assendelft, Tjard R.J. Schermer, Jacob K. Sont
Format: Article
Language:English
Published: European Respiratory Society 2020-09-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/6/3/00351-2019.full